|
|
|
|
|
|
|
|
CORA Timetable
|
Thursday, March 10, 2011
Friday, March 11, 2011
Saturday, March 12, 2011
Thursday, March 10, 2011
| |
Hall A |
Hall B |
| 08:30 |
Opening Ceremony |
|
| 09:00-10:00 |
Debate I
Switching anti-TNFα with another anti-TNFα in RA |
| 10:00-10:30 |
Lecture I
Glucocorticoid Treatment: towards the optimum strategy
Supported by an unrestricted grant from MundiPharma |
Oral Presentations
Pathogenetic clues in autoimmune rheumatic diseases
(09:00-11:00)
12 presentations |
| 10:30-11:00 |
Lecture II
Target to Treat and Tight Control in RA
Supported by an unrestricted grant from Abbott |
| 10:30-11:00 |
Coffee Break, Exhibition, and Poster Viewing |
| 11:30-13:00 |
Scientific Session A
B cell directed therapy in SLE: lights and shadows |
Scientific Session B
Early diagnosis, current and future therapies in psoriatic arthritis |
| 13:00-14:00 |
Lunch Break, Exhibition, and Poster Viewing |
| 14:00-14:30 |
Lecture III
UCTD vs Overlap Syndromes:
Resolving the Controversy |
|
| 14:30-15:30 |
Debate II
Thromboprophylaxis in aPL carriers without previous thrombosis? |
Debate III
Vaccinations in autoimmune rheumatic diseases |
| 15:30-16:00 |
Coffee Break, Exhibition, and Poster Viewing |
| 16:00-16:30 |
Lecture IV
Efficacy of biologics in practice; clinical and laboratory insights
Supported by an unrestricted grant from Pfizer |
Oral Presentations
Spondiloarthropathies and miscellanea
(16:00-17:00)
6 presentations
|
| 16:30-17:00 |
Lecture V
Abatacept: its role as first line biologic agent
Supported by an unrestricted grant from Bristol-Myers-Squibb |
| 17:00-18:40 |
Parallel Scientific Session C
Atherosclerosis in autoimmune rheumatic diseases |
Parallel Scientific Session D
Autoantibodies: are they pathogenetic or not?
|
| 19:00 |
Welcome Reception |
|
Friday, March 11, 2011
| |
Hall A |
Hall B |
| 09:00-10:00 |
Debate Session IV
High-intensity anticoagulation in prevention of arterial thrombosis recurrence
|
Oral Presentations
Novel aspects in traditional and biologic treatments of autoimmune disorders
(09:00-11:00)
12 presentations
|
| 10:00-10:30 |
Lecture VII
Current use of Methotrexate in Rheumatic Diseases
Supported by an unrestricted grant from Alfa Wasserman |
| 10:30-11:00 |
Lecture VII
Anti-TNF biologic agents: the right patient for the right therapy
Supported by an unrestricted grant from Schering-Plough |
| 11:00-11:30 |
Coffee Break, Exhibition, and Poster Viewing |
| 11:30-13:00 |
Scientific Session E
Old and new treatments for autoimmune rheumatic diseases
|
Scientific Session F
Idiopathic inflammatory myopathies |
| 13:00-14:00 |
Lunch Break, Exhibition, and Poster Viewing |
| 14:00-14:30 |
Lecture VIII
Potential role of canakinumab in the treatment of autoinflammatory syndromes
Supported by an unrestricted grant from Novartis |
|
| 14:30-15:30 |
Debate Session V
Does seronegative aps really exist? |
Debate Session VI
Fibromyalgia: a discrete entity |
| 15:30-16:00 |
Coffee Break, Exhibition, and Poster Viewing |
| 16:00-16:30 |
Lecture IX
Development of Biosimilar Products
Supported by an unrestricted grant from Sandoz |
Oral Presentations
Rheumatoid Arthritis
(16:00-17:30)
9 presentations
|
| 16:30-17:00 |
Lecture X
Early Response to TNF-Alfa-Blockers as Predictor of Long-Term Benefit in RA
Supported by an unrestricted grant from UCB |
| 17:00-17:30 |
Lecture XI
Long term treatment with Tocilizumab in RA
Supported by an unrestricted grant from Roche |
| 17:30-18:40 |
Scientific Session G
What is More Relevant in the Induction of Autoimmunity? |
Scientific Session H
Rheumatologist Faced With Neuropsychiatric Manifestations | Saturday, March 12, 2011
| |
Hall A |
Hall B |
| 09:00-10:00 |
Debate Session VII
Early Treatment in Undifferentiated Early Arthritis |
Oral Presentations
Connective tissue diseases
(09:00-11:00)
12 presentations
|
| 10:00-10:30 |
Lecture XII
Early axial spondyloarthropathies: diagnosis and management
Supported by an unrestricted grant from Abbott |
| |
Lecture XIII
Predictive factors for rituximab response in rheumatoid arthritis
Supported by an unrestricted grant from Roche |
| 11:00-11:30 |
Coffee Break, Exhibition, and Poster Viewing |
| 11:30-13:15 |
Scientific Session I
Autoinflammatory Syndromes |
Scientific Session J
From the Joints to the Heart Involvement: To Prevent or to Cure |
| 13:15-13:30 |
Closing Ceremony |
|
| 14:00-16:00 |
Post-Congress Satellite Symposium
Rheumatic Inflammatory Diseases: Myths and Reality
Sponsored by MSD | |
|
|
|
|